Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Clopidogrel in 2020: A Reappraisal
Giuseppe Patti, Giuseppe Micieli, Claudio Cimminiello, et al.
Cardiovascular Therapeutics (2020) Vol. 2020, pp. 1-12
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets
Krishna Sriram, Paul A. Insel
Physiological Reviews (2020) Vol. 101, Iss. 2, pp. 545-567
Open Access | Times Cited: 100
The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD)
Mohammed Ahmed Akkaif, Nur Aizati Athirah Daud, Abubakar Sha’aban, et al.
Molecules (2021) Vol. 26, Iss. 7, pp. 1987-1987
Open Access | Times Cited: 54
MicroRNA as Potential Biomarkers of Platelet Function on Antiplatelet Therapy: A Review
Pamela Czajka, Alex Fitas, Daniel Jakubik, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 37
The Role of the Coagulation System in Peripheral Arterial Disease: Interactions with the Arterial Wall and Its Vascular Microenvironment and Implications for Rational Therapies
Giuseppe Miceli, Maria Grazia Basso, Giuliana Rizzo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14914-14914
Open Access | Times Cited: 24
Mitochondrial Effects of Common Cardiovascular Medications: The Good, the Bad and the Mixed
Alina M. Bețiu, Lavinia Noveanu, Iasmina M. Hâncu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13653-13653
Open Access | Times Cited: 22
Association of P2RY12 Gene Variants and Non‐Genetic Factors With Clopidogrel Responsiveness in Vietnamese Patients After Percutaneous Coronary Intervention: A Cross‐Sectional Study
Hoàng Tạ Anh, Toan Nguyen Duy, Thanh Bui Duc, et al.
Journal of Clinical Laboratory Analysis (2025)
Open Access
Clopidogrel Management in Abdominal Surgery: A Comparison of Perioperative Bleeding Risks with Low-Molecular-Weight Heparin Bridging, No-Bridging and Clopidogrel Continuation Strategies
Bangsheng Hu, Junsheng Chen, Shuai Han, et al.
Clinical and Applied Thrombosis/Hemostasis (2025) Vol. 31
Open Access
Genetic Variants in Transcription Factor Binding Sites in Humans: Triggered by Natural Selection and Triggers of Diseases
Chia‐Chun Tseng, Man-Chun Wong, Wei‐Ting Liao, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4187-4187
Open Access | Times Cited: 25
Systemic platelet inhibition with localized chemotherapy by an injectable ROS-scavenging gel against postsurgical breast cancer recurrence and metastasis
Jiajia Gui, Yueting Zhu, Xue Chen, et al.
Acta Biomaterialia (2024) Vol. 177, pp. 388-399
Closed Access | Times Cited: 3
TROMBOSE VENOSA PROFUNDA
Paulo Victor Teixeira Firmino, Ítalo Eugênio de Souza Gadelha de Abreu, Matheus Eugênio de Sousa Lima
Editora Amplla eBooks (2022), pp. 231-244
Open Access | Times Cited: 14
Aspirin and clopidogrel resistance; a neglected gap in stroke and cardiovascular practice in Iran: a systematic review and meta-analysis
Mohammad Parsa‐kondelaji, Hassan Mansouritorghabeh
Thrombosis Journal (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 8
Aspirin Versus Clopidogrel as Single Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry
Yusuke Kobari, Taku Inohara, Tetsuya Saito, et al.
Circulation Cardiovascular Interventions (2021) Vol. 14, Iss. 5
Open Access | Times Cited: 19
Relationships of Proton Pump Inhibitor‐Induced Renal Injury with CYP2C19 Polymorphism: A Retrospective Cohort Study
Rika Fukui, Satoshi Noda, Yoshito Ikeda, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 115, Iss. 5, pp. 1141-1151
Open Access | Times Cited: 2
Efficacy and safety of newer P2Y12 inhibitors for acute coronary syndrome: a network meta-analysis
Yue Fei, Cheuk Kiu Lam, Bernard Man Yung Cheung
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 19
Ilaprazole and Clopidogrel Resistance in Acute Stroke Patients
In Hwan Lim, Seung Jae Lee, Byoung‐Soo Shin, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1366-1366
Open Access | Times Cited: 10
QSPR Analysis of Some Important Drugs Used in Heart Attack Treatment via Degree-Based Topological Indices and Regression Models
Abdul Hakeem, Nek Muhammad Katbar, Fazal Muhammad, et al.
Polycyclic aromatic compounds (2023) Vol. 44, Iss. 8, pp. 5237-5246
Closed Access | Times Cited: 5
Effect of chronic unpredicted mild stress-induced depression on clopidogrel pharmacokinetics in rats
Xueyao Jiang, Jing Wu, Boyu Tan, et al.
PeerJ (2022) Vol. 10, pp. e14111-e14111
Open Access | Times Cited: 8
The Effect of Formulation Variables on the Manufacturability of Clopidogrel Tablets via Fluidized Hot-Melt Granulation—From the Lab Scale to the Pilot Scale
Béla Kovács, Erzsébet-Orsolya Tőkés, Éva-Katalin Kelemen, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 391-391
Open Access | Times Cited: 1
RGB-algorithm whiteness appraisal approach for quantitative determination of clopidogrel and aspirin in presence of salicylic acid as a degradation product based on proton NMR technique
Amal A. El‐Masry, Abdallah M. Zeid
Microchemical Journal (2024) Vol. 203, pp. 110948-110948
Closed Access | Times Cited: 1
Population pharmacokinetic‐pharmacodynamic modeling of clopidogrel for dose regimen optimization based on CYP2C19 phenotypes: A proof of concept study
Yun Seob Jung, Byung Hak Jin, Min Soo Park, et al.
CPT Pharmacometrics & Systems Pharmacology (2023) Vol. 13, Iss. 1, pp. 29-40
Open Access | Times Cited: 4
Clopidogrel Dosing: Current Successes and Emerging Factors for Further Consideration
Manoranjenni Chetty, Paulien Ravenstijn, Pooja Manchandani
Clinical Pharmacology & Therapeutics (2020) Vol. 109, Iss. 5, pp. 1203-1211
Closed Access | Times Cited: 11
Intrinsic drug potential of oxazolo[5,4‐d]pyrimidines and oxazolo[4,5‐d]pyrimidines
Victor Zhirnov, Yevheniia Velihina, Oleg P. Mitiukhin, et al.
Chemical Biology & Drug Design (2021) Vol. 98, Iss. 4, pp. 561-581
Closed Access | Times Cited: 10
Purinergic signaling in myocardial ischemia–reperfusion injury
Yi Zhuang, Mei-Ling Yu, Sheng-Feng Lu
Purinergic Signalling (2022) Vol. 19, Iss. 1, pp. 229-243
Open Access | Times Cited: 7
Impact of Prasugrel and Ticagrelor on Platelet Reactivity in Patients With Acute Coronary Syndrome: A Meta-Analysis
Lulu Dai, Jiawei Xu, Yuerong Jiang, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 6
The pharmacological treatment of acute vestibular syndrome
Pasquale Viola, Federico Maria Gioacchini, Alessia Astorina, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top